Stay updated on Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial
Sign up to get notified when there's something new on the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page.

Latest updates to the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page
- Check2 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check9 days agoChange DetectedA site-wide NIH announcement appears above the 403 error page, describing the transition from “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check16 days agoChange DetectedThe footer’s site revision changes from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check23 days agoChange DetectedThe footer displays a newer ClinicalTrials.gov revision number, changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now shows a 403 Forbidden error with the site header and footer visible, and the detailed study content and related documents are no longer accessible on the page.SummaryDifference18%

- Check64 days agoChange DetectedThe site was updated from version v3.6.5 to v3.6.6. This change represents an underlying platform update that may affect UI or backend behavior but does not modify the study data.SummaryDifference0.1%

Stay in the know with updates to Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page.